The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5,7-dimethyl-N-phenyl-2-(phenylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide ID: ALA4084756
PubChem CID: 16752269
Max Phase: Preclinical
Molecular Formula: C21H19N5O
Molecular Weight: 357.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)n2nc(Nc3ccccc3)c(C(=O)Nc3ccccc3)c2n1
Standard InChI: InChI=1S/C21H19N5O/c1-14-13-15(2)26-20(22-14)18(21(27)24-17-11-7-4-8-12-17)19(25-26)23-16-9-5-3-6-10-16/h3-13H,1-2H3,(H,23,25)(H,24,27)
Standard InChI Key: OCZDFXWBMHJPPY-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
5.2044 -18.3331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2044 -19.1503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9097 -19.5548 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9097 -17.9204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6150 -18.3331 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6150 -19.1514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3931 -19.4043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8741 -18.7423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3932 -18.0804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6913 -18.7423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6456 -20.1815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9097 -17.1032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4973 -19.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0999 -18.0346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9154 -18.0368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3240 -17.3299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9153 -16.6212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0939 -16.6238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6891 -17.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0987 -20.7887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4449 -20.3515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3512 -21.5659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8019 -22.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0538 -22.9475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8539 -23.1181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4016 -22.5059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1468 -21.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
8 10 1 0
7 11 1 0
4 12 1 0
2 13 1 0
10 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
11 20 1 0
11 21 2 0
20 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.42Molecular Weight (Monoisotopic): 357.1590AlogP: 4.34#Rotatable Bonds: 4Polar Surface Area: 71.32Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.47CX Basic pKa: 1.64CX LogP: 5.41CX LogD: 5.41Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.57Np Likeness Score: -1.70
References 1. Cherukupalli S, Karpoormath R, Chandrasekaran B, Hampannavar GA, Thapliyal N, Palakollu VN.. (2017) An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold., 126 [PMID:27894044 ] [10.1016/j.ejmech.2016.11.019 ]